ConductScience.org, home

Paper6231046

Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia.

Storb R and 9 others. Br J Haematol, 1983. Cited by 151 papers, by iCite.

Cite this record

ConductScience Library. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Papers, record 6231046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6231046

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia.
PubMed
Journal
Br J Haematol
PubMed
Year
1983
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
151
iCite
Relative citation ratio, by iCite
4.55
iCite
Revised in PubMed
2019-07-04
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Storb RR
2Prentice RLR L
3Thomas EDE D
4Appelbaum FRF R
5Deeg HJH J
6Doney KK
7Fefer AA
8Goodell BWB W
9Mickelson EE
10Stewart PP

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, AplasticMajor topic
Bone Marrow TransplantationMajor topic
Graft RejectionMajor topic
Blood Transfusion
Cell Survival
Combined Modality Therapy
Cyclophosphamide
Female
HLA Antigens
Humans
Lymphocyte Culture Test, Mixed
Male
Sex Factors
Time Factors

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 15704NCI NIH HHSUnited StatesP01CA015704PubMed and NIHNIH RePORTER
CA 18029NCI NIH HHSUnited StatesP01CA018029PubMed and NIHNIH RePORTER
CA 30924NCI NIH HHSUnited StatesP01CA030924PubMed and NIHNIH RePORTER
P30CA015704NIHNIH RePORTER

Download CSV of grants

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.

PMIDTitleJournalYearIn PapersSource
29143281Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.Int J Hematol2018https://conductscience.org/library/papers/29143281PubMed
28169418Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia.Br J Haematol2017https://conductscience.org/library/papers/28169418PubMed
27159171Haploidentical HCT using an αβ T-cell-depleted graft with targeted αβ(+) cells by add-back after a reduced intensity preparative regimen containing low-dose TBI.Bone Marrow Transplant2016https://conductscience.org/library/papers/27159171PubMed
27088376Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis.Bone Marrow Transplant2016https://conductscience.org/library/papers/27088376PubMed
26797402Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.Biol Blood Marrow Transplant2016https://conductscience.org/library/papers/26797402PubMed
26149534Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure.Am J Hematol2015https://conductscience.org/library/papers/26149534PubMed
26113077Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor.J Hematol Oncol2015https://conductscience.org/library/papers/26113077PubMed
25891976Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.Br J Haematol2015https://conductscience.org/library/papers/25891976PubMed
25310303Refinement of treatment strategies in ex vivo T-cell-depleted haploidentical SCT for pediatric patients.Bone Marrow Transplant2015https://conductscience.org/library/papers/25310303PubMed
23813900
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.
Am J Hematol2013https://conductscience.org/library/papers/23813900PubMed
21917752Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution.Blood2011https://conductscience.org/library/papers/21917752PubMed
21415995Hematopoietic stem cell transplantation in thalassemia and sickle cell disease. Unicenter experience in a multi-ethnic population.Mediterr J Hematol Infect Dis2009https://conductscience.org/library/papers/21415995PubMed
20062099HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.Bone Marrow Transplant2010https://conductscience.org/library/papers/20062099PubMed
19913629The biology of allogeneic hematopoietic cell resistance.Biol Blood Marrow Transplant2010https://conductscience.org/library/papers/19913629PubMed
19130172Correlation between characteristics of unrelated bone marrow donor and cell density of total nucleated cell in bone marrow harvest.Int J Hematol2009https://conductscience.org/library/papers/19130172PubMed
18640568Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.Biol Blood Marrow Transplant2008https://conductscience.org/library/papers/18640568PubMed
18162238Graft failure after allogeneic hematopoietic cell transplantation.Biol Blood Marrow Transplant2008https://conductscience.org/library/papers/18162238PubMed
17450183
Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
Bone Marrow Transplant2007https://conductscience.org/library/papers/17450183PubMed
17272503Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.Blood2007https://conductscience.org/library/papers/17272503PubMed
16518427
Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.
Bone Marrow Transplant2006https://conductscience.org/library/papers/16518427PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6231046

GET https://conductscience.org/api/papers/v1/6231046/cited_by?page=2